-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Docusign, Raises Price Target to $70

Benzinga·09/04/2026 13:49:52
Listen to the news
UBS analyst Karl Keirstead maintains Docusign (NASDAQ:DOCU) with a Neutral and raises the price target from $54 to $70.